U.S. stocks enjoyed a solid Friday session, with the Dow Jones index adding around 200 points as investors digested a busy week of earnings and corporate news. The upbeat market mood lifted a diverse collection of stocks, from cancer treatment developers to nuclear energy providers.
CG Oncology Leads Gainers on Accelerated Trial Timeline
Leading the pack was CG Oncology Inc. (CGON), which surged 21.8% to $51.05 after delivering welcome news to investors waiting on clinical trial results. The company announced an expedited timeline for the topline data readout now expected in the first half of 2026 for the Phase 3 PIVOT-006 clinical trial comparing adjuvant intravesical cretostimogene grenadenorepvec versus surveillance in patients with intermediate-risk non-muscle invasive bladder cancer. In plain English, they're moving faster than expected, which tends to make shareholders happy.
A Wild Day for Smaller Names
Rich Sparkle Holdings Ltd (ANPA) absolutely exploded, jumping 113.6% to $51.70. The catalyst was a $39 million offering of 3 million ordinary shares at $13 per share. The stock trading well above the offering price suggests investors saw the equity raise as an opportunity rather than dilution to fear.
NovaBay Pharmaceuticals Inc. (NBY) surged 34.4% to $12.81, though the company didn't announce specific news to explain the move. Sometimes the market moves in mysterious ways.
Quanterix Corp (QTRX) gained 29.3% to $8.42 after naming Everett Cunningham as President and CEO, effective January 19. Leadership changes can energize a stock, particularly when investors view the incoming executive as capable of driving growth.




